Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system
Reexamination Certificate
2011-04-19
2011-04-19
Chung, Susannah (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Four or more ring nitrogens in the bicyclo ring system
C546S184000, C548S255000, C548S262200, C548S300100, C548S400000
Reexamination Certificate
active
07928228
ABSTRACT:
A Compound represented by the following general formula (1):wherein R1a, R1b, R1cand R1deach independently represent hydrogen, etc.; R2represents optionally substituted phenyl, etc.; R3represents optionally substituted C6-10 aryl, etc.; and Z1and Z2each independently represent hydrogen or salts thereof or hydrates of the foregoing.
REFERENCES:
patent: 6916837 (2005-07-01), Satoh et al.
patent: 7576098 (2009-08-01), Glunz et al.
patent: 7816522 (2010-10-01), Clark et al.
patent: 2002/0004608 (2002-01-01), Alig et al.
patent: 2002/0052417 (2002-05-01), Klingler et al.
patent: 2003/0181766 (2003-09-01), Satoh et al.
patent: 2004/0242627 (2004-12-01), Suzuki et al.
patent: 2004/0254376 (2004-12-01), Suzuki et al.
patent: 2005/0004197 (2005-01-01), Suzuki et al.
patent: 2005/0004204 (2005-01-01), Suzuki et al.
patent: 2005/0245592 (2005-11-01), Suzuki et al.
patent: 2008/0015199 (2008-01-01), Clark et al.
patent: 2008/0132507 (2008-06-01), Clark et al.
patent: 2009/0270433 (2009-10-01), Clark et al.
patent: 58281/80 (1980-11-01), None
patent: 0 019 586 (1980-11-01), None
patent: 1 020 434 (2000-07-01), None
patent: 1 078 917 (2001-02-01), None
patent: 1 312 602 (2003-05-01), None
patent: 1 828 152 (2007-09-01), None
patent: 2002-509924 (2002-04-01), None
patent: 2002-543176 (2002-12-01), None
patent: 2003-212837 (2003-07-01), None
patent: 2003-534311 (2003-11-01), None
patent: 2003-535844 (2003-12-01), None
patent: 1512055 (1992-07-01), None
patent: WO-99/10316 (1999-03-01), None
patent: WO-99/41231 (1999-08-01), None
patent: 99/50255 (1999-10-01), None
patent: WO-99/50255 (1999-10-01), None
patent: WO-00/35858 (2000-06-01), None
patent: WO-00/41531 (2000-07-01), None
patent: WO-00/58346 (2000-10-01), None
patent: WO-00/66545 (2000-11-01), None
patent: WO-02/085855 (2002-10-01), None
patent: WO-2004/032846 (2004-04-01), None
patent: WO-2004/101555 (2004-11-01), None
patent: WO-2006/041119 (2006-04-01), None
patent: WO-2006/062972 (2006-06-01), None
patent: WO 07/111212 (2007-10-01), None
Database WPI Week 199323, Thomson Scientific, London, GB 1993-186830, XP002540626.
Vippagunta et al., “Crystalline Solids,”Adv. Drug Delivery Rev., 48, pp. 3-26 (2001).
McMahon et al., “VEGF Receptor Signaling in Tumor Angiogenesis,”The Oncologist, 5 (suppl 1): pp. 3-10 (2000).
Fu et al., “Anti-apoptotic role . . . ,”Biochemical and Biophysical Research Comm., 349, pp. 504-512 (2006).
Pinedo et al., “Translational Research . . . ,”The Oncologist, 5 (suppl 1): pp. 1-2 (2000).
Office Action of Jun. 24, 2009 in Application No. 11/665,385.
“Cancer.” Medline Plus. (2009). Accessed Mar. 17, 2009. <http://www.nlm.nih.gov/medlineplus/cancer.html>.
Golub et al. “Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring.” Science (1999), vol. 286, 521-537.
Lala et al. “Role of nitric oxide in tumor progression: Lessons form experimental tumors.” Cancer and Metastasis Reviews (1998), 17(1), 91-106.
Notice of Allowance of Feb. 23, 2010 in U.S. Appl. No. 11/665,385.
Notice of Allowance of Feb. 23, 2010 in U.S. Appl. No. 12/234,116.
Roussel et al., “Inhibition of the Tissue Factor/Factor Vila Complex—Lead Optimisation Using Combinatorial Chemistry,” Tetrahedron, vol. 55, pp. 6219-6230 (1999).
Database WPI Week 199323, Thomson Scientific, London, GB 1993-186830, XP002540626.
Vippagunta et al., “Crystalline Solids,”Adv. Drug Delivery Rev., 48, pp. 3-26 (2001).
McMahon et al., “VEGF Receptor Signaling in Tumor Angiogenesis,”The Oncologist, 5 (suppl 1): pp. 3-10 (2000).
Notice of Allowance of Feb. 23, 2010 in U.S. Appl. No. 12/234,116.
Office Action of Dec. 28, 2009 in U.S. Appl. No. 11/723,893.
Office Action of Jul. 20, 2009 in U.S. Appl. No. 11/723,893.
Notification of Transmittal of Copies of Translation of the International Preliminary Report on Patentability (PCT/IB/338) International.Prefirainant Reward on Patentability (PCT/IB/373), and Written Opinion of the International Searching Authonty (PCT171SA/237) issued Apr. 15, 2010 in International Appiicatton No. PCT/JP2008/066944.
“Stroke,” Google Health, Accessed Nov. 6, 2010 (https://health.google.com/health/ref/Stroke).
Becker et al., “Disseminated Intravascular Coagulation,” eMedicine, Sep. 2009 (http://emedicine.medscape.com/article/779097).
Office Action issued Nov. 12, 2010, in copending U.S. Appl. No. 12/688,756.
Azuma Hiroshi
Clark Richard
Hirota Shinsuke
Horizoe Tatsuo
Inoue Atsushi
Birch & Stewart Kolasch & Birch, LLP
Chung Susannah
Eisai Co. Ltd.
EISAI R&D Management Co., Ltd.
LandOfFree
Triazolone derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazolone derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazolone derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2702811